
Global Study Reports 98.9% SVR with SOF/VEL in Over 7000 Patients With Hepatitis C
A multinational real-world study of 7,027 patients treated with sofosbuvir/velpatasvir (SOF/VEL) for hepatitis C virus (HCV) infection reported a sustained virologic response (SVR) rate of 98.9%. "We're really excited to share this data at …